Human Adoptive Transfer Core
人类收养转移核心
基本信息
- 批准号:7917918
- 负责人:
- 金额:$ 25.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-04-01 至 2015-03-31
- 项目状态:已结题
- 来源:
- 关键词:Adoptive TransferCell TransplantationCellsClinicalClinical TrialsClinical Trials DesignDataFutureGenesGoalsHematopoieticHematopoietic stem cellsHumanImmuneImmunodeficient MouseKnowledgeModelingMusNatural Killer CellsPrincipal InvestigatorRecoveryRegulatory T-LymphocyteResearch PersonnelResource SharingStem cellsT cell responseTestingUmbilical Cord BloodUmbilical Cord Blood TransplantationXenograft proceduredesignin vivoleukemiaperipheral bloodpre-clinicalprogenitorprogramsresearch studyresponsestem cell biologythymocyte
项目摘要
The aim of this core is to use a xenotransplantation murine model to provide in vivo readouts for experiments proposed in this program project. Specifically, this model will be used for the following purposes:
1. To optimize proliferation and function of T regulatory cells (Treg) for suppression of alloreactive responses.
2. To perform studies testing the hypothesis that human thymocyte progenitor cells (Tprog) will accelerate human thymopoiesis and peripheral blood T cell responses in immunodeficient mice.
3. To optimize proliferation and function of natural killer (NK) cells for leukemia therapy.
These data will in turn inform the design of future clinical trials.
The core leader will provide valuable knowledge of the stem cell biology, gene manipulations, murine models, and clinical hematopoietic cell transplantation, all relevant to this application. Core D is unique in its capability to allow two of the three Principal Investigators (who do not have access to preclinical murine models; Project 1 and 3) with a critical shared resource to enhance their scientific program.
本核心的目的是使用异种移植小鼠模型为本项目中提出的实验提供体内读数。具体来说,该模型将用于以下目的:
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jakub Tolar其他文献
Jakub Tolar的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jakub Tolar', 18)}}的其他基金
Skin-targeted Cell Therapy for Recessive Dystrophic Epidermolysis Bullosa
隐性营养不良性大疱性表皮松解症的皮肤靶向细胞疗法
- 批准号:
9244744 - 财政年份:2013
- 资助金额:
$ 25.04万 - 项目类别:
Skin-targeted Cell Therapy for Recessive Dystrophic Epidermolysis Bullosa
隐性营养不良性大疱性表皮松解症的皮肤靶向细胞疗法
- 批准号:
10693927 - 财政年份:2013
- 资助金额:
$ 25.04万 - 项目类别:
Skin-targeted Cell Therapy for Recessive Dystrophic Epidermolysis Bullosa
隐性营养不良性大疱性表皮松解症的皮肤靶向细胞疗法
- 批准号:
8502074 - 财政年份:2013
- 资助金额:
$ 25.04万 - 项目类别:
Skin-targeted Cell Therapy for Recessive Dystrophic Epidermolysis Bullosa
隐性营养不良性大疱性表皮松解症的皮肤靶向细胞疗法
- 批准号:
8836974 - 财政年份:2013
- 资助金额:
$ 25.04万 - 项目类别:
Skin-targeted Cell Therapy for Recessive Dystrophic Epidermolysis Bullosa
隐性营养不良性大疱性表皮松解症的皮肤靶向细胞疗法
- 批准号:
9020207 - 财政年份:2013
- 资助金额:
$ 25.04万 - 项目类别:
Skin-targeted Cell Therapy for Recessive Dystrophic Epidermolysis Bullosa
隐性营养不良性大疱性表皮松解症的皮肤靶向细胞疗法
- 批准号:
8639483 - 财政年份:2013
- 资助金额:
$ 25.04万 - 项目类别:
Skin-targeted Cell Therapy for Recessive Dystrophic Epidermolysis Bullosa
隐性营养不良性大疱性表皮松解症的皮肤靶向细胞疗法
- 批准号:
10490837 - 财政年份:2013
- 资助金额:
$ 25.04万 - 项目类别:
Skin-targeted Cell Therapy for Recessive Dystrophic Epidermolysis Bullosa
隐性营养不良性大疱性表皮松解症的皮肤靶向细胞疗法
- 批准号:
10249323 - 财政年份:2013
- 资助金额:
$ 25.04万 - 项目类别:
Hematopoietic Stem Cell Transposon Therapy for Severe Combined Immunodeficiency
造血干细胞转座子治疗严重联合免疫缺陷
- 批准号:
7686340 - 财政年份:2008
- 资助金额:
$ 25.04万 - 项目类别:
相似海外基金
IL-33 induced-lL-9 producing type 2 innate lymphoid cells in the regulation of acute lung injury after hematopoietic stem cell transplantation (HSCT) in pediatric patients
IL-33诱导产生IL-9的2型先天淋巴细胞在调节儿科患者造血干细胞移植(HSCT)后急性肺损伤中的作用
- 批准号:
10540768 - 财政年份:2022
- 资助金额:
$ 25.04万 - 项目类别:
Memory T cells to improve immunity after TCRab/CD19 depleted haploidentical donor stem cell transplantation for inborn errors of immunity
TCRab/CD19 耗尽的单倍相合供体干细胞移植治疗先天性免疫缺陷后,记忆 T 细胞可提高免疫力
- 批准号:
MR/W021587/1 - 财政年份:2022
- 资助金额:
$ 25.04万 - 项目类别:
Research Grant
IL-33 induced-lL-9 producing type 2 innate lymphoid cells in the regulation of acute lung injury after hematopoietic stem cell transplantation (HSCT) in pediatric patients
IL-33诱导产生IL-9的2型先天淋巴细胞在儿科患者造血干细胞移植(HSCT)后急性肺损伤的调节中
- 批准号:
10392134 - 财政年份:2022
- 资助金额:
$ 25.04万 - 项目类别:
Proteotranscriptomic regulation of homing and engraftment in hematopoietic stem and progenitor cells for hematopoietic cell transplantation
用于造血细胞移植的造血干细胞和祖细胞归巢和植入的蛋白质转录组调控
- 批准号:
10313584 - 财政年份:2021
- 资助金额:
$ 25.04万 - 项目类别:
Sex-mismatched hematopoietic cell transplantation and acquisition of B-cells specific to antigens on Y-chromosome
性别不匹配的造血细胞移植和获取对 Y 染色体抗原具有特异性的 B 细胞
- 批准号:
21K07070 - 财政年份:2021
- 资助金额:
$ 25.04万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Proteotranscriptomic regulation of homing and engraftment in hematopoietic stem and progenitor cells for hematopoietic cell transplantation
用于造血细胞移植的造血干细胞和祖细胞归巢和植入的蛋白质转录组调控
- 批准号:
10661324 - 财政年份:2021
- 资助金额:
$ 25.04万 - 项目类别:
Cell transplantation for regeneration of the inner ear hair cells
细胞移植促进内耳毛细胞再生
- 批准号:
20K18315 - 财政年份:2020
- 资助金额:
$ 25.04万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Using donor dendritic cells to optimize GvHD and GvL in allogeneic stem cell transplantation
使用供体树突状细胞优化同种异体干细胞移植中的 GvHD 和 GvL
- 批准号:
10402871 - 财政年份:2020
- 资助金额:
$ 25.04万 - 项目类别:
Using donor dendritic cells to optimize GvHD and GvL in allogeneic stem cell transplantation
使用供体树突状细胞优化同种异体干细胞移植中的 GvHD 和 GvL
- 批准号:
10052895 - 财政年份:2020
- 资助金额:
$ 25.04万 - 项目类别:
Improving haematopoietic reconstitution in blood stem cell transplantation procedures through the regulation of stem cells and their niches
通过干细胞及其生态位的调节改善血液干细胞移植过程中的造血重建
- 批准号:
MR/V005421/1 - 财政年份:2020
- 资助金额:
$ 25.04万 - 项目类别:
Research Grant














{{item.name}}会员




